Health Ministry Drafts Rule to Debar Pharma Applicants Submitting Fake or Misleading Documents
- byDoctor News Daily Team
- 31 October, 2025
- 0 Comments
- 0 Mins
New Delhi:In a major regulatory move aimed at tightening compliance and accountability within India's pharmaceutical licensing framework, the Ministry of Health and Family Welfare (MoHFW) has issued draft rules to amend the Drugs Rules, 1945, introducing provisions for debarment of applicants found guilty of submitting fake, fabricated, or misleading documents. The draft notification—G.S.R. 756(E), dated October 16, 2025 — was published by the Department of Health and Family Welfare, exercising powers under the Drugs and Cosmetics Act, 1940, after consultation with the Drugs Technical Advisory Board (DTAB). The draft is published for the information of all persons likely to be affected thereby, and notice is given that the said draft rules shall be taken into consideration on or after the expiry of a period of thirty days from the date on which the copies of the Gazette of India containing these draft rules are made available to the public. According to the proposal, new provisions titled “Debarment of applicant under this part” will be inserted across multiple sections of the Drugs Rules, including Rules 29B, 66B, 84F, 93A, 122DBA, 122Q, and 150L, empowering both Licensing Authorities and the Central Licensing Approving Authority to debar individuals or firms for a period deemed appropriate if found guilty of furnishing false or misleading information in connection with licensing, manufacturing, or related approvals. The draft rules mandate that before issuing such an order, the concerned authority must give the applicant an opportunity to show cause and communicate the reasons in writing. Aggrieved applicants may appeal within thirty days to the respective government, which will conduct an inquiry and provide a hearing before passing a final order. The Ministry has invited objections and suggestions from stakeholders within thirty days of the Gazette publication. Submissions may be sent to the Director (Drugs Regulation), MoHFW, at Room No. 407, A Wing, Nirman Bhavan, New Delhi – 110011, or emailed to drugsdiv-mohfw@gov.in Following is the draft of certain rules further to amend the Drugs Rules, 1945, which the Central Government proposes to make, in exercise of the powers conferred by subsection (1) of section 12 and subsection (1) of section 33 of the Drugs and Cosmetics Act, 1940 (23 of 1940), after consultation with the Drugs Technical Advisory Board. DRAFT RULES
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
NEET 2025: TN Health extends round 3 choice fillin...
- 31 October, 2025
DME Gujarat extends PG Ayurveda, Homeopathy round...
- 31 October, 2025
Decade-Long Study of PCI and CABG in Left Main Cor...
- 31 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!